Puma Biotechnology (PBYI) Financial Statements & Analysis

Puma Biotechnology (PBYI) Income Statement

Puma Biotechnology reported revenue of $228.37M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 0.9% from $230.47M a year earlier. Net income was $31.11M, up 2.8% year over year, a net margin of 13.6%. Gross margin was 74.5% and operating margin 16.3%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $56.50M, up 7.8% from the same quarter a year earlier.

Puma Biotechnology Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Puma Biotechnology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	228.37	230.47	235.64	228.03	253.16	225.11	272.26	251.00	27.70
Cost of Revenue	58.16	64.40	62.68	55.09	63.70	39.37	36.82	34.60	5.60
Gross Profit	170.21	166.06	172.96	172.94	189.45	185.74	235.45	216.40	22.10
Operating Expenses
Research & Development	62.07	54.94	50.38	52.24	71.87	97.65	132.85	164.90	207.80
Selling, General & Administrative	71.21	80.16	89.93	89.98	116.29	118.49	141.64	146.20	106.70
Operating Expenses	132.92	135.10	140.32	142.22	188.16	216.14	311.04	311.10	314.50
Operating Income	37.30	30.97	32.64	30.72	1.29	-30.40	-75.60	-94.70	-292.40
Other Income/Expense
Interest Income	4.08	4.72	2.61	0.81	0.16	0.49	2.80	1.80	1.26
Interest Expense	6.62	12.45	13.33	11.59	12.81	14.05	15.00	11.00	0.72
Other Income/Expense	-1.52	-6.87	0.76	-19.48	-17.45	-29.39	0.05	-18.92	0.44
Income
Income Before Tax	35.78	24.10	22.67	0.46	-28.80	-59.79	-75.54	-113.60	-292.00
Income Tax Expense	4.67	-6.18	1.08	0.46	0.32	0.21	0.05	-7.92	-2.21
Net Income	31.11	30.28	21.59	0.00	-29.13	-60.00	-75.60	-113.60	-292.00
Net Income - Continuous Operations	31.11	30.28	21.59	0.00	-29.13	-60.00	-75.60	-113.60	-292.00
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	53.34	48.08	47.52	21.89	-4.69	-35.71	-52.45	-95.21	-288.42
EBIT	37.30	36.55	36.00	12.05	-16.00	-30.40	-	-	-
Depreciation & Amortization	10.94	11.52	11.52	9.84	11.31	10.03	8.08	7.38	2.81
Earnings Per Share
Basic EPS	1.00	1.00	-	-	-1.00	-2.00	-2.00	-3.00	-8.00
Diluted EPS	1.00	1.00	-	-	-1.00	-2.00	-2.00	-3.00	-8.00
Basic Shares Outstanding	50.01	48.65	47.13	44.67	40.64	39.58	38.77	37.94	37.17
Diluted Shares Outstanding	50.65	49.10	47.55	44.93	40.64	39.58	38.77	37.94	37.17

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Puma Biotechnology Financial Statements

What was Puma Biotechnology's revenue in fiscal 2025?

Puma Biotechnology reported revenue of $228.37M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 0.9% from $230.47M a year earlier.

Is Puma Biotechnology profitable?

Yes. Puma Biotechnology earned net income of $31.11M in fiscal 2025, a net margin of 13.6%. In fiscal 2024 it earned $30.28M.

What is Puma Biotechnology's operating margin?

Puma Biotechnology's operating income was $37.30M on revenue of $228.37M in fiscal 2025, an operating margin of 16.3%, compared with 13.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition